Selection and Procurement Sample Clauses
The Selection and Procurement clause outlines the process by which goods, services, or contractors are chosen and acquired for a project or organization. Typically, this clause details the criteria for evaluating potential suppliers, the steps for soliciting bids or proposals, and the approval process for final selections. For example, it may require competitive bidding or specify preferred vendors. Its core function is to ensure transparency, fairness, and efficiency in purchasing decisions, thereby reducing the risk of favoritism or wasteful spending.
Selection and Procurement. ▇▇▇▇ shall select and procure the Dedicated Equipment at CLIENT’s sole cost, plus the applicable ▇▇▇▇ markup (as set forth in Section 5.2) to cover handling costs, in accordance with the Product Specifications. ▇▇▇▇ shall use commercially reasonable efforts to determine whether the Dedicated Equipment conforms to the applicable Product Specifications and will work in the Facility for purpose stated in the Project Plan.
Selection and Procurement. Catalent shall select and, with Client’s prior written approval, procure the Dedicated Equipment at Client’s sole cost[***]. Catalent shall use [***] to determine whether the Dedicated Equipment conforms to the applicable specifications and will work in the Facility for purpose stated in the Project Plan. [***] = CERTAIN CONFIDENTIAL INFORMATION OMITTED CONFIDENTIAL Page 19 of 48
Selection and Procurement. To the extent that Catalent is required to purchase any Dedicated Equipment, Catalent shall select and procure the Dedicated Equipment at Client’s sole cost [***]. Catalent shall use [***] efforts to determine whether the Dedicated Equipment conforms to the applicable specifications and will work in the Facility for purpose stated in the Project Plan.
Selection and Procurement. Because the number of livers of ‘perfect quality’ is limited, such an organ is not available for all patients on the waiting list. Therefore, livers with additional risk factors also have to be considered for transplantation. To what extent we can accept additional risk factors is not clear and it is difficult to define strict criteria. This is especially difficult as these criteria change in time and are subject to experience of clinicians and the balance between the number of available organ donors and patients waiting. Livers that are currently not used for transplantation have to be considered most promising to facilitate more transplantations to cope with the current shortage. With the development of the ET-DSRI, in Chapter 2 we have made an effort to classify organs according to their chance of being accepted for transplantation. The ET- DSRI model showed a high accuracy to predict the use of livers for transplantation indicated by a c-index of 0.75. However, because relatively few livers are not used for transplantation, the model can estimate the chance of discard only for a small proportion of livers with a certainty of >80%. The ET-DSRI included fifteen factors that were statistically, significantly associated with non-utilization. It includes male sex, higher donor age, history of diabetes, malignancy, drug abuse, use of vasopressors, BMI category, serum sodium, cause of death, DCD donor type and laboratory values like CRP, bilirubin, ASAT, ALAT, INR and GGT. Several of these factors, GGT, INR, CRP and a history of drug abuse and vasopressors were not included in the original DSRI1. These differences might be caused by several reasons. First of all, there are significant differences between the US and Eurotransplant of livers reported for allocation1 and livers that are actually transplanted2. This is, for example, illustrated by the median donor age of 42 years old compared to 53 years old for livers reported for allocation in the UNOS and ET region, respectively1. Also, livers that were actually transplanted seemed to be of a higher average quality in the US2. Significant epidemiological differences between the US and Europe could be of importance in this matter3–6. Secondly, regulation on center-specific outcomes in the US could be an important reason for stricter acceptance criteria. When transplantation centers are primarily rewarded for outcome after transplantation, the acceptance of marginal organs for transplantation is discouraged. Alt...
Selection and Procurement. ImmunoGen shall select and procure the Dedicated Equipment. ImmunoGen shall use commercially reasonable efforts to ensure that the Dedicated Equipment conforms to the applicable Requirements, will work in its facility and is otherwise suitable for the intended purposes.
Selection and Procurement. Lead Agency shall be responsible for representing all Member Agencies in the selection of a Consultant, including all procurement, contracting, budgeting, and payment activities required to retain the Consultant to deliver the Project Report. Any contract with Consultant shall be with Lead Agency as the contracting party for the Member Agencies.